Clinical Trial Update: Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of SGLT2 inhibitors in pre-diabetic individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Fasting Glucose
• Impaired Glucose Tolerance
• Prediabetic State

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Yangjin | Conditions: Prediabetic State, Impaired Fasting Glucose | Phase 2 | Status: UNKNOWN